Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 27% ± 13% | |
peripheral blood | 12 studies | 22% ± 4% | |
lung | 9 studies | 21% ± 4% | |
breast | 5 studies | 20% ± 2% | |
bone marrow | 4 studies | 20% ± 5% | |
eye | 4 studies | 24% ± 8% | |
prostate | 4 studies | 21% ± 4% | |
adipose | 4 studies | 24% ± 12% | |
lymph node | 3 studies | 23% ± 2% | |
liver | 3 studies | 36% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 9319.38 | 245 / 245 | 100% | 325.14 | 501 / 502 |
breast | 100% | 17539.09 | 459 / 459 | 99% | 376.24 | 1106 / 1118 |
brain | 99% | 4708.39 | 2613 / 2642 | 100% | 144.86 | 703 / 705 |
adrenal gland | 100% | 16277.36 | 258 / 258 | 95% | 134.27 | 218 / 230 |
lung | 100% | 8034.52 | 576 / 578 | 94% | 108.76 | 1090 / 1155 |
thymus | 100% | 6048.51 | 651 / 653 | 94% | 69.62 | 568 / 605 |
liver | 100% | 5537.66 | 226 / 226 | 91% | 81.04 | 369 / 406 |
uterus | 100% | 4294.15 | 170 / 170 | 89% | 69.69 | 408 / 459 |
skin | 92% | 4354.43 | 1668 / 1809 | 95% | 104.78 | 449 / 472 |
kidney | 96% | 2738.66 | 85 / 89 | 87% | 66.88 | 780 / 901 |
bladder | 100% | 4079.00 | 21 / 21 | 82% | 63.97 | 413 / 504 |
ovary | 100% | 3775.76 | 180 / 180 | 78% | 47.59 | 336 / 430 |
intestine | 96% | 4490.61 | 931 / 966 | 70% | 48.34 | 370 / 527 |
esophagus | 98% | 3868.58 | 1422 / 1445 | 66% | 54.57 | 120 / 183 |
pancreas | 31% | 561.93 | 101 / 328 | 91% | 62.56 | 162 / 178 |
stomach | 49% | 2187.15 | 177 / 359 | 70% | 44.89 | 199 / 286 |
adipose | 100% | 15109.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 104.95 | 29 / 29 |
spleen | 100% | 5541.42 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5032.72 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 5811.10 | 887 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 69.16 | 42 / 45 |
heart | 90% | 2733.76 | 778 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 44.88 | 58 / 80 |
muscle | 8% | 134.20 | 63 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0042761 | Biological process | very long-chain fatty acid biosynthetic process |
GO_0034626 | Biological process | fatty acid elongation, polyunsaturated fatty acid |
GO_0036109 | Biological process | alpha-linolenic acid metabolic process |
GO_0019367 | Biological process | fatty acid elongation, saturated fatty acid |
GO_0043651 | Biological process | linoleic acid metabolic process |
GO_0034625 | Biological process | fatty acid elongation, monounsaturated fatty acid |
GO_0035338 | Biological process | long-chain fatty-acyl-CoA biosynthetic process |
GO_0006636 | Biological process | unsaturated fatty acid biosynthetic process |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0097447 | Cellular component | dendritic tree |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0043025 | Cellular component | neuronal cell body |
GO_0016020 | Cellular component | membrane |
GO_0030425 | Cellular component | dendrite |
GO_0005515 | Molecular function | protein binding |
GO_0009922 | Molecular function | fatty acid elongase activity |
Gene name | ELOVL5 |
Protein name | Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5) Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5) Elongation of very long chain fatty acids protein (EC 2.3.1.199) (Very-long-chain 3-oxoacyl-CoA synthase) |
Synonyms | ELOVL2 hCG_2001424 PRO0530 |
Description | FUNCTION: Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. May participate to the production of monounsaturated and of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. . FUNCTION: Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. May participate in the production of monounsaturated and of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators (By similarity) . In conditions where the essential linoleic and alpha linoleic fatty acids are lacking it is also involved in the synthesis of Mead acid from oleic acid (By similarity). . |
Accessions | B3KWH9 ENST00000542638.5 ENST00000370918.8 [Q9NYP7-2] ENST00000370913.5 [Q9NYP7-3] Q9NYP7 ENST00000304434.11 [Q9NYP7-1] A0A0A0MTI6 |